Changes in the Routes 2018 publication
There were a few minor changes applied throughout the publication. Below is a full list of the changes:
- D09.1 is no longer mapped to bladder and renal pelvis subgroups, now mapped to urethra only.
- C80 repeated row has been removed.
- C16.0 is no longer mapped to oesophagus, now mapped to stomach only.
- C64 no longer mapped to renal pelvis, now mapped to kidney only.
- Re-labelling of bladder to bladder (invasive)
- Re-labelling of bladder (invasive and non-invasive) to bladder (insitu).
- All files now include an "All malignant neoplasm" breakdown
- "Sex" has been renamed to "Gender" throughout.
- Cancer alliance geographies have been updated to those for 2018.
All figures and spreadsheets have been updated to match these changes.
1 December 2022 09:30 AM
Summary
Routes to Diagnosis categorises the pathways that lead to a patient’s diagnosis of cancer. These results provide an overview of the results for 2006 to 2018, showing the trends over time for all malignant neoplasms (excluding non-melanoma skin cancer) and a snapshot of results in 2018 for female breast, colorectal, lung and prostate cancers.
Overall, emergency presentations continue to decline gradually, with the proportion of those diagnosed through the Two Week Wait referral route increasing as it has done since 2006.
Resources
Last edited: 1 December 2022 9:49 am